News NHS and Drayson to pilot intensive care digital sensors Chelsea and Westminster Hospital to adopt Drayson wireless environment sensors.
News NHS and Drayson Technologies unveil groundbreaking digital h... NHS and Drayson Technologies unveil groundbreaking digital health deal
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
